Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 433.54 (2026-05-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Vertex Pharmaceuticals Incorporated (VRTX) had Net Income of $1.03B for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$2.99B
Net Income
$1.03B
$392.80M
$2.59B
$1.85B
$1.14B
$114.80M
$1.25B
$1.25B
$1.03B
$1.03B
$1.03B
$1.03B
$1.14B
$1.19B
254.10M
256.30M
$4.06
$4.02
Balance Sheet Financials
$11.73B
$1.61B
$14.75B
$26.48B
$3.88B
--
$3.24B
$7.12B
$19.36B
$17.86B
$19.36B
254.16M
Cash Flow Statement Financials
$1.43B
$-431.90M
$-538.80M
$5.09B
$5.50B
$417.10M
$166.40M
--
--
Fundamental Metrics & Ratios
3.02
--
--
--
--
86.85%
38.10%
38.10%
--
41.95%
34.53%
$1.29B
--
--
--
0.11
0.22
1.50
60.15
5.33%
5.78%
3.89%
5.33%
$76.18
$5.05
$5.57